Malachite Green

Identification

Generic Name
Malachite Green
DrugBank Accession Number
DB03895
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 329.458
Monoisotopic: 329.20177381
Chemical Formula
C23H25N2
Synonyms
  • malachite green cation
  • malachite green(1+)
External IDs
  • CI 42000

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UHTH-type transcriptional regulator QacRNot AvailableStaphylococcus haemolyticus
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Diphenylmethanes
Direct Parent
Diphenylmethanes
Alternative Parents
Dialkylarylamines / Aniline and substituted anilines / Secondary ketimines / Azomethines / Organopnictogen compounds / Hydrocarbon derivatives / Organic cations
Substituents
Amine / Aniline or substituted anilines / Aromatic homomonocyclic compound / Azomethine / Dialkylarylamine / Diphenylmethane / Hydrocarbon derivative / Organic cation / Organic nitrogen compound / Organonitrogen compound
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
iminium ion (CHEBI:44107)
Affected organisms
Not Available

Chemical Identifiers

UNII
AWT9R95TV1
CAS number
10309-95-2
InChI Key
VFCNQNZNPKRXIT-UHFFFAOYSA-N
InChI
InChI=1S/C23H25N2/c1-24(2)21-14-10-19(11-15-21)23(18-8-6-5-7-9-18)20-12-16-22(17-13-20)25(3)4/h5-17H,1-4H3/q+1
IUPAC Name
4-{[4-(dimethylamino)phenyl](phenyl)methylidene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium
SMILES
CN(C)C1=CC=C(C=C1)C(C1=CC=CC=C1)=C1C=CC(C=C1)=[N+](C)C

References

General References
Not Available
PubChem Compound
11295
PubChem Substance
46505481
ChemSpider
10821
BindingDB
214729
RxNav
1547770
ChEBI
44107
ChEMBL
CHEMBL1181633
ZINC
ZINC000003953819
PDBe Ligand
MGR
Wikipedia
Malachite_green
PDB Entries
1jup / 1q8n / 3bqz / 3br0 / 3btc / 3btl / 3hti / 5vlg

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00138 mg/mLALOGPS
logP0.25ALOGPS
logP1.29Chemaxon
logS-5.4ALOGPS
pKa (Strongest Basic)4.52Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count1Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area6.25 Å2Chemaxon
Rotatable Bond Count3Chemaxon
Refractivity131.58 m3·mol-1Chemaxon
Polarizability39.53 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.5643
Blood Brain Barrier+0.7198
Caco-2 permeable+0.6321
P-glycoprotein substrateNon-substrate0.5936
P-glycoprotein inhibitor INon-inhibitor0.6474
P-glycoprotein inhibitor IINon-inhibitor0.5747
Renal organic cation transporterNon-inhibitor0.5959
CYP450 2C9 substrateNon-substrate0.7272
CYP450 2D6 substrateNon-substrate0.7573
CYP450 3A4 substrateSubstrate0.5753
CYP450 1A2 substrateInhibitor0.5787
CYP450 2C9 inhibitorNon-inhibitor0.8225
CYP450 2D6 inhibitorNon-inhibitor0.5732
CYP450 2C19 inhibitorNon-inhibitor0.8028
CYP450 3A4 inhibitorNon-inhibitor0.667
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.7973
Ames testNon AMES toxic0.9132
CarcinogenicityCarcinogens 0.8444
BiodegradationNot ready biodegradable0.9944
Rat acute toxicity2.5102 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9172
hERG inhibition (predictor II)Non-inhibitor0.7075
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-03dl-5189000000-71c693258b35f2694dda
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-190.17926
predicted
DeepCCS 1.0 (2019)
[M+H]+192.53728
predicted
DeepCCS 1.0 (2019)
[M+Na]+198.63042
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Staphylococcus haemolyticus
Pharmacological action
Unknown
General Function
Transcription factor activity, sequence-specific dna binding
Specific Function
Transcriptional repressor of qacA. Binds to IR1, an unusually long 28 bp operator, which is located downstream from the qacA promoter and overlaps its transcription start site. QacR is induced from...
Gene Name
qacR
Uniprot ID
P0A0N5
Uniprot Name
HTH-type transcriptional regulator QacR
Molecular Weight
22174.175 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52